IPS & G-CON launch prefabricated cleanrooms biz

By Flora Southey contact

- Last updated on GMT

GettyImages/CANUNAL
GettyImages/CANUNAL
Integrated Project Services (IPS) and G-CON Manufacturing are collaborating to supply prefabricated cleanrooms for biomanufacturing, known as PODs.

The US-based firms will operate under the iCON brand, and cater to drug makers and contract manufacturing organisations (CMOs).

Under the agreement, G-CON is responsible for POD design, fabrication and site installation, and IPS will provide engineering, architecture, procurement and construction management support to customers.

G-CON said unlike traditional cleanroom structures, its cleanrooms – which include aseptic fill/finish, personalised medicine and production process platform capabilities – are mobile, scalable, and can be repurposed after use.

“PODs provide a prefabricated cleanroom that is autonomous, mobile and easy to clean,” ​said G-CON.

Reduced timelines & delayed spending

According to senior director of IPS Tom Piombino, G-CON will begin fabrication early at its factory in College Station, Texas, in order to reduce project timelines.

“iCON delivers rapid capacity scaling in a multi-platform, multi-product environment and seeks to reduce the long term delay and capital investment associated with change,” ​he said.

Operating companies with pending clinical data, indications or drug approvals can delay their capital expenditures longer, because the schedule to establish capacity takes less time, he told us.

“In a traditional project delivery scenario, companies often need to begin spending significant capital several years prior to knowing if their clinical data is trending positively,” ​said Piombino.

 ​[The iCON structure] allows companies to close the gap between getting position clinical/approval data and spending capital,” ​he added.

Regionalisation

Firms based in areas where local labor and material costs are lower than at the manufacturing site in Texas, US, will also benefit from ‘regionalisation’, said Piombino.

“If the project site is in an area of the world where the local labor and material costs are lower, then it make sense to source these locally for the parts of the facility that are less technical in nature and can be constructed quickly,” ​he told us.

“For a platform iCON 4x2000L mAb facility, we estimate that 40% of the overall project installed costs can typically be sourced locally by the iCON Construction Management team,” ​he explained.

Related news

Related products

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the...

Partner with Experts in Precision Medicine

Partner with Experts in Precision Medicine

CellCarta | 17-Jan-2022 | Product Brochure

At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. Our broad technology offering is designed...

Related suppliers

Follow us

Products

View more

Webinars